AQR Capital Management - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 160 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$115,000
-12.2%
28,0690.0%0.00%
Q4 2017$131,000
-34.2%
28,0690.0%0.00%
Q3 2017$199,000
-80.6%
28,069
-61.2%
0.00%
-100.0%
Q4 2014$1,024,000
-10.9%
72,379
-13.4%
0.00%
-33.3%
Q3 2014$1,149,000
-20.5%
83,579
-11.1%
0.00%
-25.0%
Q2 2014$1,445,000
-12.5%
93,979
-3.0%
0.00%
-20.0%
Q1 2014$1,651,000
+4.0%
96,879
-21.0%
0.01%0.0%
Q4 2013$1,587,000
+28.2%
122,5790.0%0.01%
+25.0%
Q3 2013$1,238,000
+48.6%
122,579
+9.9%
0.00%
+33.3%
Q2 2013$833,000
+664.2%
111,579
+168.9%
0.00%
Q4 2012$109,00041,5000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$30.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders